Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Approval

CTech 24/7

  • Intel CEO backs $44M round for Speedata as Israeli chipmaker targets big data bottlenecks
  • “Bioconvergence is not just a scientific evolution – it’s our strategic bet on the future”
  • “Bioconvergence is not just a scientific evolution – it’s our strategic bet on the future”
  • Full list of Israeli high-tech funding rounds in 2025
More stories in CTech

Approval

1 stories about Approval
  • Teva CEO Kåre Schultz. Photo: Sivan Farage

    Market Indifferent to European Approval of Teva's Migraine Drug

    02.04.19|Lilach BaumerTeva's injection, one of three similar migraine drugs already approved in the U.S., is the third to receive European approval after Amgen Inc. and Novartis AG and Eli Lilly

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive